Introduction Hyperosmolar therapy with mannitol or hypertonic saline (HTS) is the primary medical management strategy for elevated intracranial pressure (ICP). La solución salina isoncótica-hipertónica [NaCl 7,2%/ HES (/0,5) 6%] y manitol (20%), en dosis única con carga osmolar equivalente, fueron efectivos y . isoncótica hipertônica versus manitol (20%) durante neuroanestesia eletiva manitol versus solución isoncótica hipertónica (SIH), durante la neurocirugía.

Author: Meztihn Braktilar
Country: Lesotho
Language: English (Spanish)
Genre: Career
Published (Last): 28 September 2012
Pages: 403
PDF File Size: 5.91 Mb
ePub File Size: 2.32 Mb
ISBN: 998-8-15089-719-4
Downloads: 35375
Price: Free* [*Free Regsitration Required]
Uploader: Grokus

Two comprehensive reviews have summarized this evidence. Methodology for the control of intracranial pressure with hypertonic mannitol.

Solucion Hipertonica vs Manitol en HEC

The treatment of tromboangiitis obliterans by intravenous injection of hypertonic salt solution. A prospective, randomized comparison of pentobarbital and mannitol. Second, jipertonica gold-standard therapy should ideally have a more favorable side-eff ect profi le than its alternatives.

Hyperosmolar therapy for intracranial hypertension. A total of 36 studies describe HTS treatment of IH in adults and children from etiologies including trauma, stroke, tumor, infec-tion, and intracranial and subarachnoid hemorrhage.

There was a problem providing the content you requested

Five well-designed trials were found, with patients and episodes of elevated ICP. Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock.

One theory is that they reduce water content in the brain, and a second theory is that they reduce manitool and cerebrovascular resistance, giving rise to compensatory vasoconstriction and reduced CBV. The value of hypertonic mannitol solution in decreasing brain mass and lowering cerebro-spinal-fluid pressure. Neurocrit Care Th is, in turn, will allow the considerable cost and eff ort of large-scale clinical trials to be sloucion towards questions to which the answers are not already evident.


Effect of mannitol on cerebral blood flow and cerebral perfusion pressure in human TBI.

InVialet et al. It is also used to lower ICP in patients who have not responded to prior mannitol therapy, and this measure further reduces Zolucion, raises CPP and increases brain tissue oxygenation without adding side effects. Two studies showed prolonged control of ICP, and 1 study showed that patients treated with HTS had less IH episodes per day than those who received mannitol.


Effect of osmotic agents on regional cerebral blood flow in traumatic brain injury. The review included 36 articles, of which 10 were prospective randomized controlled, 1 non-randomized prospective, 15 observational prospective and 10 retrospective studies. Predictable reduction of intracranial hypertension with hypertonic saline hydroxyethyl starch: They pointed out that the odds ratio for the control of intracranial hypertension was 1.

Hypertonic saline as a safe and efficacious treatment of intracranial hypertension. Regardless of its aetiology, intracranial hypertension creates a secondary lesion because it lowers CPP, predisposing the brain to ischaemia and triggering brain tissue displacement with the risk of compressing vital structures.

Microscopic urinalysis has revealed vacuoles in tubular cells consistent with osmotic nephrosis, which generally does not result in permanent injury and reverts after the drug is removed. In the present article I make the case that current evidence supports HTS, not mannitol, as the better choice for gold-standard therapy for medical management of intracranial hypertension.


A recent meta-analysis quantifi es the comparative effi cacy of the two agents [7]. Pharmacokinetics and effects of mannitol on hemodynamics, blood and cerebrospinal fluid electrolytes and osmolality during intracranial surgery.

Solucion Hipertonica vs Manitol en HEC

Wise BL, Chater N. CritCare Med But it was not untilwhere it is used in the clinic for the first vez. ARF associated with the use of mannitol has been described, but its mechanism is unclear. Its plasma half-life is 2.

Evidence supporting mannitolMuch of the literature regarding mannitol is reported from the trauma population and is subsequently general ized to other solicion. Fluid replacement is required to avoid hypovolemia and subsequent secondary ischaemia or ICP elevation from reflex vasodilation of cerebral arterioles.

Cerebral blood flow augmentation in patients with severe subarachnoid hemorrhage. Elevated ICP hipertoonica occur in TBI in the presence of haematomas or cerebral oedema, and continues to be an important focus of patient care. Are you looking for